NIK activation -> IKKa homodimer activation -> phosphorylation of p100 + ubiquitination -> p52 generation and formation of dimer with RelB -> translocation into nucleus to induce gene expression
Can take advantage of NFkappaB signalling for more viral replication/spread and to evade immune responses, although it mostly results in an antiviral effect
Activated by multiple pathways, e.g., canonical pathway (triggered by TNF-a, viral nucleic acid) or alternative pathway (triggered by TNFSF ligands like CD40L)
Includes NFkappaB binding sites in viral genome, downregulates NFkappaB-interacting long non-coding RNA (NKILA), encoded proteins suppress immune response and inhibit apoptosis of infected cells
IKK complex formation -> phosphorylation of IKBa -> ubiquitin-dependent degradation of IKBa -> release of NFkappaB into nucleus -> induction of gene expression